health Toripalimab Extends Survival in Nasopharyngeal and Esophageal Cancers
Phase III trials JUPITER-02 and JUPITER-06 show toripalimab combined with chemotherapy significantly improves overall survival for nasopharyngeal and esophageal squamous cell carcinoma patients.
